De novo cholesterol biosynthesis is a key metabolic vulnerability in rhabdomyosarcoma. Its inhibition halts cell ...
Shift verification effort from a single, time-consuming flat run to a more efficient, distributed, and scalable process.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback